MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-23-0022980
Medrish Pharmaceuticals Private Limited
Medrish Pharmaceuticals Private Limited - pharma in Muzaffarpur, Bihar, India. Directors, charges & compliance details.
Revenue · FY 2025
₹87.48 Lakh
▲ 168% YoY
Net profit · FY 2025
₹1.24 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹1.4 Lakh
EBITDA margin 1.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Medrish Pharmaceuticals Private Limited
Data last updated:
Medrish Pharmaceuticals Private Limited is a private limited company based in Muzaffarpur, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24299BR2020PTC045522. Its GSTIN is 10AANCM3373Q1Z1 (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ratnesh Kumar and Sudha Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Suresh Sah Vill – Moraul Ward No – 08, Muzaffarpur, Bihar, India – 844120.
As per the financials filed for FY 2025, the company reported a revenue of ₹87.48 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.24 Lakh (net margin 1.4%) and EBITDA of ₹1.4 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 105% over three years.
Court records list 1 case involving the company, including 1 filed by the company.
Medrish Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-23-0022980).
Company Details of Medrish Pharmaceuticals Private Limited
CIN U24299BR2020PTC045522
Registration Number 045522
Incorporation Date 18 February 2020
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-BR-23-0022980
Key People
Ratnesh Kumar Director Sudha Kumari Director Recognitions & Rankings of Medrish Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Suresh Sah Vill – Moraul Ward No – 08, Muzaffarpur, Bihar, India – 844120
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Medrish Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Medrish Pharmaceuticals Private Limited
The main business activity of Medrish Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medrish Pharmaceuticals Private Limited FY 2025 filings available
Medrish Pharmaceuticals Private Limited reported revenue of ₹87.48 Lakh (up 168% YoY) for FY 2025.
Revenue · FY 2025
₹87.48 Lakh ▲ 168%
Net profit · FY 2025
₹1.24 Lakh margin 1.4%
EBITDA · FY 2025
₹1.4 Lakh margin 1.6%
Compounded Annual Growth Rate (CAGR) of Medrish Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 168%
3 years · compounded
▲ 105%
EBITDA CAGR growth
1 year
▲ 105%
Revenue has grown at a compounded annual rate (CAGR) of 105% over three years, including 168% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medrish Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.4 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.24 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medrish Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medrish Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Medrish Pharmaceuticals Private Limited
Medrish Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ratnesh Kumar | Director | 18 Feb 2020 | 6 Years 8 Months | Current |
| Sudha Kumari | Director | 27 Sep 2021 | 5 Years 0 Months | Current |
Peer Comparison of Medrish Pharmaceuticals Private Limited
Medrish Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medizincure Private Limited | ₹87.65 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Aligarh, Uttar Pradesh, India |
| Mak Well Healthcare OPC Private Limited | ₹87.61 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Akola, Maharashtra, India |
| Dawawale Pharmaceuticals Limited | ₹87.59 Lakh (FY 2023) | •••• | •••• | -66.0% | •••• | Noida, Uttar Pradesh, India |
| Rayon Healthcare Private Limited | ₹87.59 Lakh (FY 2024) | •••• | •••• | 118.0% | •••• | Delhi, India |
| Sparsh Optimum Healthcare Private Limited | ₹87.55 Lakh (FY 2024) | •••• | •••• | -6.0% | •••• | Bhubaneswar, Odisha, India |
| Medrish Pharmaceuticals Private Limited this company | ₹87.48 Lakh (FY 2025) | •••• | •••• | 168.0% | •••• | Muzaffarpur, Bihar, India |
| Yatan Pharmaceuticals Private Limited | ₹87.33 Lakh (FY 2025) | •••• | •••• | 77.0% | •••• | Mumbai, Maharashtra, India |
| Shailesh Pharmaceuticals Private Limited | ₹87.28 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Uttar Pradesh, India |
| Tirupati Medicos Pvt Ltd | ₹87.22 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Kolkata, West Bengal, India |
| Orvil Pharmaceuticals Private Limited | ₹87.16 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Howrah, West Bengal, India |
| Misha Biotech Private Limited | ₹87.14 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Medrish Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Medrish Pharmaceuticals Private Limited
Medrish Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Medrish Pharmaceuticals Private Limited
Medrish Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Medrish Pharmaceuticals. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal miscellaneous application | Filed by the company against Government of Gujarat | Disposed |
Premium access
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Medrish Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Medrish Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medrish Pharmaceuticals Private Limited
Medrish Pharmaceuticals Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Sudha Kumari ceased to be Additional Director on 18 Nov 2021.
AGM
Medrish Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medrish Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Ceased
Sudha Kumari ceased to be Additional Director.
Appointed
Sudha Kumari was appointed as Director.
Ceased
Suresh Sah ceased to be Director.
Appointed
Ratnesh Kumar was appointed as Director.
Incorporation
18 Feb 2020
Medrish Pharmaceuticals Private Limited was registered on 18 Feb 2020 with Roc Patna & aged 6 years 8 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Medrish Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medrish Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medrish Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medrish Pharmaceuticals Private Limited
Medrish Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AANCM3373Q1Z1 | Bihar | Active | 06 Mar 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medrish Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medrish Pharmaceuticals Private Limited
Medrish Pharmaceuticals is an active private limited company based in Muzaffarpur, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 February 2020 (6+ years old) and is registered under CIN U24299BR2020PTC045522.
Medrish Pharmaceuticals reported revenue of ₹87.48 Lakh for FY 2025 (up 168% YoY).
Medrish Pharmaceuticals has 2 current directors:
- Ratnesh Kumar - Director
- Sudha Kumari - Director
Medrish Pharmaceuticals reported a net profit of ₹1.24 Lakh (net margin 1.4%) and EBITDA of ₹1.4 Lakh (EBITDA margin 1.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medrish Pharmaceuticals is 105% over three years. In the latest year (FY 2025) revenue rose 168%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medrish Pharmaceuticals is 10AANCM3373Q1Z1, registered in Bihar.
The CIN (Corporate Identification Number) of Medrish Pharmaceuticals is U24299BR2020PTC045522. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medrish Pharmaceuticals has 1 court case on record: 1 filed by the company.
Medrish Pharmaceuticals was incorporated on 18 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Medrish Pharmaceuticals by revenue are Medizincure Private Limited, Mak Well Healthcare OPC Private Limited, Dawawale Pharmaceuticals Limited, Rayon Healthcare Private Limited, Sparsh Optimum Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Sudha Kumari ceased to be Additional Director on 18 Nov 2021. Sudha Kumari was appointed as Director on 27 Sep 2021. Suresh Sah ceased to be Director on 27 Sep 2021. Medrish Pharmaceuticals has 4 board changes on record in total.